Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas Bieber
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 662-680
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
Svenja Müller, Laura Maintz, Thomas Bieber
Allergy (2024) Vol. 79, Iss. 6, pp. 1501-1515
Open Access | Times Cited: 44
Dissolving microneedle patch loaded with adipokines-enriched adipose extract relieves atopic dermatitis in mouse via modulating immune disorders, microbiota imbalance, and skin barrier defects
Jingyan Guan, Kaiqi Chen, Feng Lu, et al.
Journal of Tissue Engineering (2025) Vol. 16
Open Access | Times Cited: 1
Air pollution and skin diseases: A comprehensive evaluation of the associated mechanism
Xiaoyu Gu, Zhengrui Li, Juan Su
Ecotoxicology and Environmental Safety (2024) Vol. 278, pp. 116429-116429
Open Access | Times Cited: 14
Structurally Oriented Carbon Dots as ROS Nanomodulators for Dynamic Chronic Inflammation and Infection Elimination
Renhao Nie, Jianhong Zhang, Qingyan Jia, et al.
ACS Nano (2024) Vol. 18, Iss. 33, pp. 22055-22070
Closed Access | Times Cited: 12
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
Teng‐Li Lin, Yi‐Hsuan Fan, Kuo-Sheng Fan, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access | Times Cited: 9
Biomarkers for phenotype-endotype relationship in atopic dermatitis: a critical review
Chang Ook Park, Su Min Kim, Kwang Hoon Lee, et al.
EBioMedicine (2024) Vol. 103, pp. 105121-105121
Open Access | Times Cited: 7
Disease modification in chronic spontaneous urticaria
Marcus Maurer, Pavel Kolkhir, Manuel P. Pereira, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2396-2413
Open Access | Times Cited: 7
Dupilumab: Mechanism of action, clinical, and translational science
Marc R. McCann, Matthew P. Kosloski, Christine Xu, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 7
Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification
Claudia Hülpüsch, Robin Rohayem, Matthias Reiger, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 31-41
Closed Access | Times Cited: 6
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis
Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 4
Macrophage P2Y6R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses
Li Yin, Enming Zhang, Tianqi Mao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4360-4377
Open Access | Times Cited: 4
Patterns of Addiction in Chronic Skin Diseases: A Comparative Analysis of Addictions and Influencing Factors in Atopic Dermatitis and Psoriasis
Roxana Mazilu, Stefanie Ziehfreund, Tilo Biedermann, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv41350-adv41350
Open Access
Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis
Sophie Forster, Annette Boegel, Simona Despa, et al.
Veterinary Dermatology (2025)
Open Access
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases
Marek Lommatzsch, Katharina Blümchen, Lisa A. Beck, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103050-103050
Open Access
What Does Long-Term Control in Atopic Dermatitis Look Like?
Shanthi Narla, Zelma C. Chiesa Fuxench, Katrina Abuabara, et al.
Dermatitis (2025)
Closed Access
Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
Mengmeng Li, Jiangyi Wang, Qingfeng Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Investigating Efficacy of Atopic Dermatitis Systemic Therapeutics After Discontinuation Part I: Biologics.
Naiem T. Issa, Rama Abdin, Kabir Al-Tariq, et al.
PubMed (2025) Vol. 18, Iss. 2, pp. 33-37
Closed Access
Systemtherapie der Neurodermitis und Psoriasis im Kindes- und Jugendalter
Michael Sticherling
Deleted Journal (2025)
Closed Access
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration
Claudia Traidl‐Hoffmann, Jamie Afghani, Cezmi A. Akdiş, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2605-2624
Open Access | Times Cited: 4
Atopic dermatitis and IgE-mediated food allergy
H. Mark Kenney, Jennifer Battaglia, Katherine Herman, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 3, pp. 262-277
Closed Access | Times Cited: 3
The journey toward disease modification in cow milk protein allergy
Rita Nocerino, Laura R. Carucci, Serena Coppola, et al.
Immunological Reviews (2024) Vol. 326, Iss. 1, pp. 191-202
Open Access | Times Cited: 3
Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study
Serena Yun‐Chen Tsai, Jonathan M. Gaffin, Elena B. Hawryluk, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2748-2758
Closed Access | Times Cited: 3
Nature's pharmacy at risk: Unveiling the hidden molecular secrets of phytotherapy in the age of globalization
Claudia Traidl‐Hoffmann
Allergy (2024) Vol. 79, Iss. 6, pp. 1413-1415
Open Access | Times Cited: 2
Interleukin antagonists for atopic dermatitis: a new era of therapy
Aikaterini Tsiogka, Eleni Paschou, Dimitra Koumaki, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 549-559
Closed Access | Times Cited: 2
Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseases
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Ricardo Ruíz‐Villaverde, et al.
JEADV Clinical Practice (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top